Lannett has confirmed filing of an abbreviated new drug application for a generic version of GlaxoSmithKline’s Advair Diskus (fluticasone/salmeterol) in the US, becoming the latest company to formally pursue a rival to the respiratory blockbuster.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?